<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36226231</PMID><DateRevised><Year>2022</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2050-3121</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>SAGE open medicine</Title><ISOAbbreviation>SAGE Open Med</ISOAbbreviation></Journal><ArticleTitle>Persistence of COVID-19 symptoms beyond 3&#x2009;months and the delayed return to the usual state of health in Saudi Arabia: A cross-sectional study.</ArticleTitle><Pagination><StartPage>20503121221129918</StartPage><MedlinePgn>20503121221129918</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20503121221129918</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/20503121221129918</ELocationID><Abstract><AbstractText Label="UNLABELLED">A substantial number of COVID-19 survivors describe ongoing symptoms long after the acute phase. This so-called post-COVID-19 syndrome or long COVID occurs irrespective of initial disease severity.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">This cross-sectional study aims to describe and characterise the prevalence of persistent COVID-19 symptoms beyond three months and to evaluate the risk factors for the delayed return to the usual state of health.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">An electronic survey was developed, piloted, and conducted during the first wave of the COVID-19 pandemic. The survey consisted of questions exploring socio-demographic data, comorbidities, COVID-19 disease (diagnosis, presenting symptoms, management, and persistent symptoms), and the return to the usual state of health. Participants were users of social media platforms. We received results from 746 respondents. One hundred thirty-six responses were excluded due to a self-diagnosis of COVID-19. Respondents reporting a COVID-19 diagnosis 3 months or more prior to the study (N&#x2009;=&#x2009;213) were included in the analysis. Predictors of the delayed return to the usual state of health were identified by logistic regression.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Three months or more after a COVID-19 diagnosis, almost half of the respondents, 109 (51.2%), had residual symptoms. The five most prevalent persistent symptoms were fatigue (13.6%), altered sense of smell (12.7%), muscle aches (10.3%), headache (9.9%), and body aches (8.5%). When questioned regarding the return to baseline health, 152 (71.4%) answered in the affirmative. The total number of chronic medical conditions was determined as a statistically significant predictor for the delayed return to the usual state of health.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Three months or more after acute COVID-19 infection, 5 out of 10 survivors experienced persistent symptoms, and 3 out of 10 reported a delayed return to baseline health. Considering the overall burden of COVID-19 disease, this can pose health and socio-economic challenges. Therefore, health systems need support in managing long COVID and improving long-term COVID-19 outcomes.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alkwai</LastName><ForeName>Hend M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0001-6396-9263</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalifa</LastName><ForeName>Amany M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Ahmed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Surgery, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alnajib</LastName><ForeName>Alfatih M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Surgery, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshammari</LastName><ForeName>Khaznah A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>General Directorate of Health Affairs in Ha'il, Ha'il, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alrashidi</LastName><ForeName>Muslima M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>General Directorate of Health Affairs in Ha'il, Ha'il, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Hussain G</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Department of Pathology, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>SAGE Open Med</MedlineTA><NlmUniqueID>101624744</NlmUniqueID><ISSNLinking>2050-3121</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">chronic COVID syndrome</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 syndrome</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>2</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36226231</ArticleId><ArticleId IdType="pmc">PMC9548451</ArticleId><ArticleId IdType="doi">10.1177/20503121221129918</ArticleId><ArticleId IdType="pii">10.1177_20503121221129918</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Health Organization. WHO Coronavirus
(COVID-19) Dashboard, https://covid19.who.int/
(2022, accessed January 17,
2022).</Citation></Reference><Reference><Citation>Perego E, Callard F, Stras L, et al.. Why the patient-made term &#x2018;long covid&#x2019; is needed. Wellcome Open Research 2020; 5: 224.</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made long covid. Soc Sci Med 2020; 268: 113426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-Haulers. J Med Virol 2020; 93: 2555&#x2013;2556.</Citation><ArticleIdList><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall M. The lasting misery of coronavirus long-haulers. Nature 2020; 585(7825): 339&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>
Kalter L.
Fauci introduces new acronym for long COVID at White House
briefing, https://www.medscape.com/viewarticle/946419 (2021,
accessed 23 November 2021).</Citation></Reference><Reference><Citation>Rando HM, Bennett TD, Byrd JB, et al.. Challenges in defining long COVID: striking differences across literature, electronic health records, and patient-reported information. MedRxiv 2021; 3: 21253896.</Citation></Reference><Reference><Citation>
NICE. Covid-19 rapid guideline: managing the
long-term effects of covid-19, https://www.nice.org.uk/guidance/ng188/chapter/4-Planning-care
(accessed 1 November 2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A&#x2019;Court C, et al.. Management of post-acute covid-19 in primary care. BMJ 2020; 2020: m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DA, O&#x2019;Brien KK. Conceptualising long COVID as an episodic health condition. BMJ Glob Health 2021; 6(9): e007004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (Long COVID): a scoping review. Front Med 2021; 8: 750378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591053</ArticleId><ArticleId IdType="pubmed">34790680</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al.. Characterising long COVID: a living systematic review. BMJ Glob Health 2021; 6(9): e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al.. Extrapulmonary manifestations of COVID-19. Nature Med 2020; 26: 1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud MH, Alghamdi FA, Alghamdi GA, et al.. Study of post-COVID-19 syndrome in Saudi Arabia. Cureus 2021; 13(9): e17787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8495763</ArticleId><ArticleId IdType="pubmed">34659998</ArticleId></ArticleIdList></Reference><Reference><Citation>Alharthy A, Abuhamdah M, Balhamar A, et al.. Residual lung injury in patients recovering from COVID-19 critical illness. J Ultrasound Med 2021; 40(9): 1823&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pubmed">33185316</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Hammad O, Alnazzawi A, Babkair H, et al.. COVID-19 infection in academic dental hospital personnel; a cross-sectional survey in Saudi Arabia. Int J Environ Res Public Health 2021; 18: 10911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536019</ArticleId><ArticleId IdType="pubmed">34682648</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsofayan YM, Althunayyan SM, Khan AA, et al.. Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J Infect Public Health 2020; 13(7): 920&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833063</ArticleId><ArticleId IdType="pubmed">32534945</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O&#x2019;Brien K, et al.. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thoraci Soc 2021; 18: 997&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al.. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID&#x2013;19 in a multistate health care systems network &#x2013; United States, March-June 2020. Morbid Mortal Weekly Rep 2020; 69: 993&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cellai M, O&#x2019;Keefe JB. Characterisation of prolonged COVID-19 symptoms in an outpatient telemedicine clinic. Open Forum Infect Dis 2020; 7: ofaa420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543492</ArticleId><ArticleId IdType="pubmed">33117851</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz JN, Chang LC, Sangha O, et al.. Can comorbidity be measured by questionnaire rather than medical record review. Med Care 1996; 34(1): 73&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">8551813</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S, Benatti SV, Casati M, et al.. Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation. Epidemiol Infect 2021; 149: e32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, et al.. Long COVID in the Faroe islands: a longitudinal study among nonhospitalised patients. Clin Infect Dis 2020; 73: e4058&#x2013;e4063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, et al.. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax 2021; 76(4): 405&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al.. Long covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur 2021; 8: 100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, et al.. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep 2022; 12: 995020220623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al.. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27(1): 89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, et al.. Post-discharge persistent symptoms and health-related quality of life after hospitalisation for COVID-19. J Infect 2020; 81: e4&#x2013;e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, et al.. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax 2021; 76(4): 399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al.. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 2021; 4: e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Parente-Arias P, Barreira-Fernandez P, Quintana-Sanjuas A, et al.. Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019. Am J Otolaryngol 2021; 42(5): 102648&#x2013;102648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358151</ArticleId><ArticleId IdType="pubmed">33799139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, et al.. Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study. Eur J Neurol 2021; 28(10): 3348&#x2013;3359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>